752.65
-24.40 (-3.14%)
AARTIPHARM • 20 Jan, 2026 | 03:29 PM
1Y Annualised Return
▲14.34%
3Y Annualised Return
▲39.60%
Aarti Pharmalabs Stock Performance
|
|
|
Aarti Pharmalabs Company background
Founded in: 2019
Managing director: Hetal Gogri Gala
Aarti Pharmalabs Limited was initially incorporated as Aarti Organics Limited in 2019. The name of the Company was changed to Aarti Pharmachem Limited from Aarti Organics Limited in July, 2021 and to Aarti Pharmalabs Limited in 2022. Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India. It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anticancer, AntiAsthma, AntiHypertensive etc.In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005 commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022.In 202122, the Pharmaceutical Division was demerged from Aarti Industries Limited into its wholly owned subsidiary, Aarti Pharmalabs Limited, via Scheme of Arrangement for Demerger, thus making it effective on October 17, 2022 and operational from July 1, 2021. Thereafter, Company commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023.The RD centre in Nerul, Navi Mumbai became fully operational in FY 2024. The Company commenced operations for its semicommercial block at the USFDA intermediate manufacturing site in Vapi in FY24. The Xanthine capacity enhanced to 5000 TPA in 2024.
Aarti Pharmalabs Financial Highlights
For the full year FY2025–2026, revenue
reached ₹2125.19 crore and profit touched at
₹272.4 crore. As of Dec '25, Aarti Pharmalabs’s market capitalisation stood at ₹6,822.57 crores.
Shareholding as of Dec '25 shows promoters holding 43.1%, with FIIs at
7.7%, DIIs at 7.7%, and public at 41.5%.
Aarti Pharmalabs Share Price Today
As of 20 Jan 2026, Aarti Pharmalabs share price is ₹752.6. The stock opened at ₹779 and had closed at ₹777 the previous day. During today’s trading session, Aarti Pharmalabs share price moved between ₹750.20 and ₹779.00, with an average price for the day of ₹764.60. Over the last 52 weeks, the stock has recorded a low of ₹568.10 and a high of ₹971.00. In terms of performance, Aarti Pharmalabs share price has declined by 20.9% over the past six months and has increased by 14.34% over the last year.
Aarti Pharmalabs SIP Return Calculator
₹5,000
Over the past
Total Investment of ₹0
Monthly SIP of ₹5,000 would have become ₹0 in 3 years with a gain of ₹0 (+0.00%)
Aarti Pharmalabs Fundamental
Market Cap (in crs)
6,822.57
Face Value
5
Turnover (in lacs)
1,499.29
Key Metrics
Qtr Change %
32.49% Gain from 52W Low
-9.7
Dividend yield 1yr %
Below industry Median
0.7
Aarti Pharmalabs Key Financials
View moreLoading chart...
Aarti Pharmalabs Quarterly Revenue
418.33 Cr | 386.19 Cr | 563.78 Cr | 537.78 Cr | 458.03 Cr |
Aarti Pharmalabs Yearly Revenue
2125.19 Cr | 1857.5 Cr | 1947.55 Cr | 1202.46 Cr |
Aarti Pharmalabs Quarterly Net Profit/Loss
28.57 Cr | 51.3 Cr | 88.34 Cr | 73.99 Cr | 54.62 Cr |
Aarti Pharmalabs Yearly Net Profit/Loss
272.4 Cr | 216.9 Cr | 193.49 Cr | 122.25 Cr |
Aarti Pharmalabs Result Highlights
Result Summary
-
Aarti Pharmalabs Ltd reported a 7.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 9.5%.
-
Its expenses for the quarter were up by 18.3% QoQ and down 3.0% YoY.
-
The net profit decreased 43.6% QoQ and decreased 48.9% YoY.
-
The earnings per share (EPS) of Aarti Pharmalabs Ltd stood at 3.08 during Q2 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Aarti Pharmalabs Technical Analysis
Moving Averages Analysis
752.65
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
Day EMA5
769.70
Day EMA10
765.00
Day EMA12
763.00
Day EMA20
757.10
Day EMA26
755.00
Day EMA50
759.90
Day EMA100
780.50
Day EMA200
780.90
Delivery & Volume
Loading chart...
Delivery Volume %
Day
46.70%
Week
43.80%
Month
35.10%
Delivery & Volume
Day Rs | 97061 Rs | 207654 Rs |
Week Rs | 132046 Rs | 301139 Rs |
Month Rs | 82292 Rs | 234187 Rs |
Resistance & Support
760.62
Pivot
Resistance
First Resistance
771.03
Second Resistance
789.42
Third Resistance
799.83
Support
First Support
742.23
Second support
731.82
Third Support
713.43
Relative Strength Index
49.47
Money Flow Index
71.50
MACD
8.01
MACD Signal
5.14
Average True Range
25.68
Average Directional Index
18.05
Rate of Change (21)
3.46
Rate of Change (125)
-20.88
Aarti Pharmalabs Peer comparison
Compare382.20 -6.95 (-1.79%)▼ | |
169.47 -3.62 (-2.09%)▼ | |
859.65 -9.45 (-1.09%)▼ | |
459.75 -20.05 (-4.18%)▼ | |
421.45 -15.90 (-3.64%)▼ | |
530.00 -32.55 (-5.79%)▼ |
Aarti Pharmalabs Latest News
Aarti Pharmalabs Share Price FAQs
Please be aware that Aarti Pharmalabs stock prices are subject to continuous fluctuations due to various factors.
Invest in Aarti Pharmalabs
Popular Stocks | |||||||||
46.34 -1.64 (-3.42%)▼ | |||||||||
116.13 -4.77 (-3.95%)▼ | |||||||||
337.85 -6.15 (-1.79%)▼ | |||||||||
2,055.10 -79.50 (-3.72%)▼ | |||||||||
129.94 -4.65 (-3.45%)▼ | |||||||||
320.30 -11.00 (-3.32%)▼ | |||||||||
183.56 -4.71 (-2.50%)▼ | |||||||||
269.60 -11.75 (-4.18%)▼ | |||||||||
409.35 -3.45 (-0.84%)▼ | |||||||||
352.95 -10.25 (-2.82%)▼ | |||||||||
Top Gainers | |||||||||
1,185.00 +4.80 (+0.41%)▲ | |||||||||
931.20 +3.30 (+0.36%)▲ | |||||||||
Top Losers | |||||||||
269.60 -11.75 (-4.18%)▼ | |||||||||
933.20 -36.25 (-3.74%)▼ | |||||||||
2,055.10 -79.50 (-3.72%)▼ | |||||||||
265.50 -10.15 (-3.68%)▼ | |||||||||
1,613.80 -61.60 (-3.68%)▼ | |||||||||
Open Demat Account